Neuroimaging biomarkers and cognitive function in non-CNS cancer and its treatment: Current status and recommendations for future research

Andrew J. Saykin, Michiel B. de Ruiter, Brenna C. McDonald, Sabine Deprez, Daniel H.S. Silverman

Research output: Contribution to journalReview article

37 Scopus citations

Abstract

Cognitive changes in patients undergoing treatment for non-central nervous system (CNS) cancers have been recognized for several decades, yet the underlying mechanisms are not well understood. Structural, functional and molecular neuroimaging has the potential to help clarify the neural bases of these cognitive abnormalities. Structural magnetic resonance imaging (MRI), functional MRI (fMRI), diffusion tensor imaging (DTI), MR spectroscopy (MRS), and positron emission tomography (PET) have all been employed in the study of cognitive effects of cancer treatment, with most studies focusing on breast cancer and changes thought to be induced by chemotherapy. Articles in this special issue of Brain Imaging and Behavior are devoted to neuroimaging studies of cognitive changes in patients with non-CNS cancer and include comprehensive critical reviews and novel research findings. The broad conclusions that can be drawn from past studies and the present body of new research is that there are structural and functional changes associated with cancer and various treatments, particularly systemic cytotoxic chemotherapy, although some cognitive and fMRI studies have identified changes at pre-treatment baseline. Recommendations to accelerate progress include wellpowered multicenter neuroimaging studies, a better standardized definition of the cognitive phenotype and extension to other cancers. A systems biology framework incorporating multimodality neuroimaging, genetics and other biomarkers will be highly informative regarding individual differences in risk and protective factors and disease- and treatment-related mechanisms. Studies of interventions targeting cognitive changes are also needed. These next steps are expected to identify novel protective strategies and facilitate a more personalized medicine for cancer patients.

Original languageEnglish (US)
Pages (from-to)363-373
Number of pages11
JournalBrain Imaging and Behavior
Volume7
Issue number4
DOIs
StatePublished - Jan 1 2013

Keywords

  • Biomarkers
  • Cancer
  • Chemotherapy
  • Cognition
  • Genetics
  • Neuroimaging.MRI
  • Personalized medicine
  • PET

ASJC Scopus subject areas

  • Radiology Nuclear Medicine and imaging
  • Behavioral Neuroscience
  • Cellular and Molecular Neuroscience
  • Cognitive Neuroscience
  • Neurology
  • Psychiatry and Mental health
  • Clinical Neurology

Fingerprint Dive into the research topics of 'Neuroimaging biomarkers and cognitive function in non-CNS cancer and its treatment: Current status and recommendations for future research'. Together they form a unique fingerprint.

  • Cite this